ArticleCanada communicable disease report = Releve des maladies transmissibles au Canada2026
Laboratory diagnosis of pertussis: A survey on provincial public health laboratory methods.
Article in Canada communicable disease report = Releve des maladies transmissibles au Canada, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Pertussis, a vaccine preventable respiratory illness caused by the bacterium Objective: To examine the breadth and depth of pertussis strain surveillance currently being carried out across Canada. Methods: A survey was sent to all ten provincial public health laboratories inquiring how pertussis was diagnosed or identified in the laboratory, including the polymerase chain reaction (PCR) diagnostic methods, bacteriological culture, identification and strain characterization such as molecular typing and antibiotic susceptibility testing. Results: Nine of the ten provincial laboratories provided responses. Five provincial laboratories reported performing bacteriological culture, and some only from specimens that tested positive by PCR. Long-term storage of submitted and historical specimens took place in six laboratories. Identification of Conclusion: Given the global increase in pertussis, with the emergence of macrolide-resistant and pertactin-deficient strains, strain characterization should be added to the Canadian national pertussis surveillance program.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.